November 6, 2018 (Meeting 121)
Canadian Agency for Drugs and Technologies in Health
Heather Logan, Acting Vice-President, Pharmaceutical Reviews
Patented Medicine Prices Review Board
Douglas Clark, Executive Director
October 30, 2018 (Meeting 119)
atypical Hemolytic Uremic Syndrome Canada
Caryn Vowles, Board Member
Mary Jane Vowles, Board Member, Canada
Department of Health
Catherine Parker, Director General, Biologics and Genetic Therapies Directorate, Health Products and Food Branch
John Patrick Stewart, Director General, Therapeutic Products Directorate
Karen Reynolds, Executive Director, Office of Pharmaceuticals Management Strategies
Liv-A-Little Foundation
Erin Little, President
October 25, 2018 (Meeting 118)
As an individual
Ian Stedman , Osgoode Hall Law School, York University
Joel Lexchin, Professor Emeritus, School of Health Policy and Management, York University
Michael Brudno, Professor and Scientific Director, Centre for Computational Medicine, Hospital for Sick Children
Children's Hospital of Eastern Ontario (CHEO)
Alex MacKenzie, Clinician Scientist
Janssen Inc. Pharmaceutical Companies of Johnson & Johnson
Jacqueline Dobson, Government Affairs and Policy Manager, Government Affairs and Market Access
Stacey Silverberg, Stakeholder Engagement Manager, Government Affairs and Market Access
October 4, 2018 (Meeting 114)
As an individual
Craig Campbell, MD, Department Pediatrics and Neurology, Children's Hospital London Health Sciences Centre
Doug Coyle, Professor, School of Epidemiology, Public Health and Preventive Medicine, University of Ottawa
Dr. Julian Midgley, Paediatric Nephrologist
The Isaac Foundation
Andrew McFadyen, Executive Director
September 27, 2018 (Meeting 112)
Amyotrophic Lateral Sclerosis Society of Canada
Tammy Moore, Chief Executive Officer
Canadian Organization for Rare Disorders
Durhane Wong-Rieger, President and Chief Executive Officer
Maureen Smith, Board Secretary
Department of Health
Catherine Parker, Director General, Biologics and Genetic Therapies Directorate, Health Products and Food Branch
John Patrick Stewart, Director General, Therapeutic Products Directorate
Karen Reynolds, Executive Director, Office of Pharmaceuticals Management Strategies